This inventor holds 5 USPTO granted patents and 1 published patent application. Top assignees: The Rockefeller University, The General Hospital Corporation, Other. Active years: 1996-2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 751 
1 out of 3,079 
1 out of 834,601 Years Active: 1996-2006
Title: The Innovative Contributions of Svetlana Mojsov
Introduction
Svetlana Mojsov is a prominent inventor based in New York, NY (US). She has made significant contributions to the field of biomedical research, particularly in the area of peptide hormones and their applications in treating diabetes. With a total of 5 patents to her name, her work has had a profound impact on medical science.
Latest Patents
One of her latest patents is focused on insulinotropic hormone derivatives and their uses. This invention pertains to derivatives of glucagon-like peptide I (GLP-1), specifically GLP-1 (7-37), which have been found to exhibit insulinotropic activity. The patent includes a composition comprising an acid addition salt of GLP-1 (7-37) and a method for treating type II diabetes mellitus by administering these derivatives to patients.
Another significant patent involves a receptor for peptide hormones that play a role in energy homeostasis. This invention relates to a second common PACAP/VIP receptor (PACAP/VIP R-2 or R-2B) cDNA expressed in human adipocytes. The receptor recognizes PACAP-38 and vasoactive intestinal polypeptide (VIP) with similar affinity and is coupled to the cAMP-mediated signal transduction pathway. The broad distribution of this receptor in human tissues suggests its potential role in mediating physiological effects in various peripheral tissues.
Career Highlights
Svetlana has worked with esteemed institutions such as The Rockefeller University and The General Hospital Corporation. Her research has contributed to a deeper understanding of peptide hormones and their implications for human health.
Collaborations
Throughout her career, Svetlana has collaborated with notable colleagues, including Yang Wei and Joel F. Habener. These collaborations have further enriched her research and innovations in the field.
Conclusion
Svetlana Mojsov's innovative work in peptide hormone research has led to significant advancements in the treatment of diabetes and our understanding of energy homeostasis. Her contributions continue to influence the biomedical field and inspire future research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile